Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 4/2011

01-12-2011 | Original Paper

Disconnection of chamber and catheter as a complication of central venous catheter type port-a-cath

Authors: S. Kostic, V. Kovcin, M. Granić, D. Jevdic, N. Stanisavljevic

Published in: Medical Oncology | Issue 4/2011

Login to get access

Abstract

The use of a central vein catheter (CVC) type port-a-cath(VPS), apart from the comfort it provides to the patient undergoing chemotherapy, also carries certain complications. In this study, our patient was subjected to chemotherapy after a radical breast cancer operation and was given a CVC type VPS. After further care, a rare complication was verified—disconnection of the chamber and catheter, which one was visually identified in the right heart chamber. As the patient was vitally endangered, she was immediately hospitalized and the catheter was removed by catheterization of the right femoral vein, with scopic imaging. Early diagnosis and localization of the problem prevented more severe complications and mortality.
Literature
1.
Vescia S, Baumgartner AK, Jacobs VR, et al. Management of venous port systems in oncology:a review of current evidence. Ann Oncol. 2008;19:9–15.PubMedCrossRef
2.
Kuriakose J, Colon-Otero G, Paz-Fumagalli R. Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters :a 5-year single–institution retrospective study. J Vasc Interv Radiol. 2002;13:179–84.PubMedCrossRef
3.
Mansfield PF, Hohn DC, Fornage BD, et al. Complication and failure of subclavian-vein catheterization. N Engl J Med. 1994;331:1735–8.PubMedCrossRef
4.
Yildizeli B, Lacin T, Batirel HF, et al. Complications and management of long-termcentral venous access catheters and ports. J Vasc Access. 2004;5(4):174–8.PubMed
5.
Bouza E. Intravascular catheter–related infections: a growing problem, the search for better solutions. Clin Microbiol Infect. 2002;8(5):255.PubMedCrossRef
6.
Agnelli G, Verso M. Therapy insight: venous–catheter- related thrombosis in cancer patients. Nature Clin Pract. 2006;3(4):214–22.CrossRef
7.
Verso M, Agnelli G. Venous thromboembolism associated with long term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21:3665–75.PubMedCrossRef
8.
Bern M, Lokich J, Sabina R, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med. 1990;112:423–8.PubMed
9.
ÓGrady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2002;30:476–89.CrossRef
10.
Bern M, Lokich J, Sabina R, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med. 1990;112:423–8.PubMed
11.
Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg. 1998;22:12–6.PubMedCrossRef
12.
Lokich JJ, Bothe A, Benotti P, Moore C. Complications and management of implanted venous access catheters. J Clin Oncol. 1985;3:710–7.PubMed
13.
Angela Wai-Chi L, Ch Yuh-Min, Kuang-Yao Y, Chun-Ming T, Reury-Perng P. Disconnection of a venous port-a-cath followed by embolization after saline flush: rare case report. Jpn J Clin Oncol. 1999;29(12):643–5.CrossRef
14.
Karin Anna H, Tobias W, Volker H, Maximilian R. Interventional radiological procedures in impaired function of surgically implanted catheter-port systems. Cardiovasc Intervent Radiol. 2001;24(1):31–6.CrossRef
15.
Bernhard G, Ulf Karl T, Pert P, Michael W, Enrique Lopez H, Roland F. Radiological interventions for correction of central venous port catheter migrations. Cardiovasc Intervent Radiol. 2007;30(4):668–74.CrossRef
16.
Rauthe G, Altmann C. Complications in connection with venous port systems: prevention and therapy. Eur J Surg Oncol. 1998;241:192–9.
Metadata
Title
Disconnection of chamber and catheter as a complication of central venous catheter type port-a-cath
Authors
S. Kostic
V. Kovcin
M. Granić
D. Jevdic
N. Stanisavljevic
Publication date
01-12-2011
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9615-z

Other articles of this Issue 4/2011

Medical Oncology 4/2011 Go to the issue

Original Paper

AXIN2 polymorphism and its association with prostate cancer in a Turkish population

Original Paper

Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy

Original Paper

Down-regulation of miR-126 expression in colorectal cancer and its clinical significance

Original Paper

Body mass index and waist circumference are predictor biomarkers of breast cancer risk in Iranian women

Original paper

Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo

Original Paper

MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits